Vav1 - vav 1 oncogene Gene
Also Known as Vav; vav-T
Species: Mus musculus
Gene Type: protein coding
Gene ID: 22324
Summary
Enables guanyl-nucleotide exchange factor activity and phosphorylation-dependent protein binding activity. Acts upstream of or within several processes, including integrin-mediated signaling pathway; neutrophil chemotaxis; and positive regulation of natural killer cell mediated cytotoxicity. Located in cell-cell junction. Is expressed in several structures, including dorsal aorta; extraembryonic component; hemolymphoid system; pancreas; and reproductive system. Orthologous to human VAV1 (vav guanine nucleotide exchange factor 1). [provided by Alliance of Genome Resources, Apr 2022]
Vav1 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001163815.1 | NP_001157287.1 | proto-oncogene vav isoform 2 |
| NM_001163816.1 | NP_001157288.1 | proto-oncogene vav isoform 3 |
| NM_011691.4 | NP_035821.3 | proto-oncogene vav isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
proto-oncogene vav |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(9)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-168625 | MRT-6160 | 99.51% | Unkown | |
| HY-131598C | 6-Thio-GTP tetrasodium | Inhibitor | 99.7% | Unkown |
| HY-168624 | VAV1 degrader-2 | 98.15% | Unkown | |
| HY-175453 | MRT-23227 | 99.45% | Unkown | |
| HY-RS15612 | VAV1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-179119 | AB19 | Inhibitor | / | Unkown |
| HY-182765 | VAV1 degrader-4 | / | Unkown | |
| HY-RS20834 | Vav1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27348 | Vav1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service